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FOREFRONTS IN NEPHROLOGY: ION CHANNELOPATHIES
Introduction
“Ion Channelopathies: Hereditary Dysfunction of Ion mutations in more than 25 different ion channel-encod-
Channels” was the theme of a jointly organized Interna- ing genes (Table 1). In fact, most of these discoveries
tional Society of Nephrology Forefronts in Nephrology have been made since 1991, and the only current specula-
and American Society of Nephrology Basic Science Con- tion is how many more disorders affecting other ion
ference held at the Skytop Lodge amid the breathtaking channel genes will be identified in the future. There have
autumn scenery of the Pocono Mountains in western been many surprises along the way: chloride channels in
Pennsylvania. The conference was an opportunity to X-linked nephrolithiasis, calcium channels in hypoka-
gather many prominent scientists from around the world lemic periodic paralysis, potassium channels in Bartter’s
for the sole purpose of discussing the role of ion channel syndrome, and others.
gene mutations in inherited disease processes. In fact, Studies of diseases caused by genetic defects in ion
this was the largest meeting ever held that was dedicated channels have brought forth new information along two
solely to ion channel disease syndromes, and perhaps scientific frontiers. As with the discovery of any genetic
we can look forward to other similar meetings in the defect, work in the ion channel disease field has made
future. The conference was originally conceived by Steve significant contributions to revealing the fundamental
Hebert and was developed in conjunction with Bill Gug- molecular pathogenesis of disorders involving a wide
gino and Bruce Stanton. variety of disease processes. Included in these accom-
plishments have been the recognition of the molecular
basis for certain forms of familial hypertension, syn-
dromes of inherited renal salt and water wasting, nephro-
lithiasis, a variety of inherited muscle diseases, suddenEVOLUTION OF ION CHANNELOPATHIES
cardiac death, deafness, familial ataxias, and epilepsy.Ion channels are integral membrane proteins that me-
Defining the molecular pathogenesis of a disease is adiate the rapid and selective movement of charged inor-
critical step toward developing new diagnostic and thera-ganic solutes and water across cell membranes. After
peutic strategies. The second scientific area that ion chan-more than 50 years of investigation, it is widely appreci-
nel disease research has contributed has been in theated that ion channels are vital to most cellular and
elucidation of the fundamental biology of ion channelphysiological functions in virtually all living organisms.
proteins. Because many genetic mutations affect criticalIon channels participate in secretion and reabsorption in
ion channel functions, many researchers have been ableepithelial tissues, membrane excitability in nerve, muscle
to discern important relationships between function andand cardiac cells, signal transduction and endocrine
structure. These advances have contributed to our basicgland function, and the control of cell volume. In addi-
understanding of how ion channels work, and this willtion to these diverse and critical physiological functions,
ultimately contribute greatly to the development of phar-ion channels are also well known targets for a variety of
macologic agents that target these molecules. Studies ofpharmacological agents, such as anti-arrhythmics/local
ion channel disorders have helped quench a seeminglyanesthetics, anticonvulsants, antihypertensives, diuret-
insatiable appetite for understanding the basic functionalics, antidiabetic drugs, and anti-anginal agents.
biology of ion channel proteins, including structure–Before 1989, the concept of a genetic defect in an ion
function relationships, modulation by accessory sub-channel gene was speculative. Research during the past
units, and appreciation of their cellular biology.10 years has revealed a startling wealth and diversity of
genetic syndromes caused by mutations in genes encod-
ing ion channel proteins. Now more than 30 human ge-
CONFERENCE OVERVIEWnetic diseases have been identified in association with
In view of the great potential for discovery of new ion
channels and ion channel diseases, there has been strong
Key words: ion channel gene, inherited diseases, cell volume, signal interest among a variety of biomedical scientists to exam-
transduction, gene mutation.
ine this field in depth. In particular, the opportunities to
Received for publication November 1, 1999 advance our understanding of disorders affecting renal
fluid and electrolyte transport, including hypertension,Ó 2000 by the International Society of Nephrology
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Table 1. Time line of ion channel disease discoveries provided the incentive for the International Society of
Nephrology in conjunction with the American Society1989 Cystic fibrosis (CFTR) [1, 2]
of Nephrology to jointly sponsor this conference. The1991 Malignant hyperthermia susceptibility (muscle Ca release
channel, RYR1) [3] intent of the conference was to stimulate new ideas that
Hyperkalemic periodic paralysis (muscle Na channel, SCN4A) would ultimately lead to greater advances in ion channel[4, 5]
disease biology, as well as improved diagnostic and thera-
1992 Paramyotonia congenita (muscle Na channel, SCN4A) [6, 7]
peutic modalities. An eclectic mix of scientists was as-Recessive generalized myotonia (muscle Cl channel, CLCN1) [8]
sembled to provide opportunities for cross-fertilization1993 Autosomal dominant myotonia congenita—Thomsen’s disease
(muscle Cl channel, CLCN1) [9] of ideas and expertise. The conference served to dissemi-
Central core disease (muscle Ca release channel, RYR1) [10, 11] nate information about ion channel disease research and
Hyperekplexia (glycine receptor, GLRA1) [12]
provided a forum for sharing the latest experimental
1994 Liddle’s syndrome (epithelial Na channel, SCNN1B, SCNN1G)
approaches to studying these fascinating syndromes.[13]
Autosomal recessive nephrogenic diabetes insipidus (renal The conference was organized into six main sessions,
water channel, AQP2) [14] two poster sessions, and three state-of-the-art lectures.
Dent’s disease (X-linked nephrolithiasis; renal Cl channel,
The organizational structure focused on common mecha-CLCN5) [15, 16]
Episodic ataxia with myokymia (K channel, KCN4A) [17] nisms of ion channel dysfunction to facilitate the goals
Hypokalemic periodic paralysis (muscle Ca channel, of the conference. By all accounts, this plan was a tre-CACNLA3) [18]
mendous success. The following paragraphs briefly sum-
1995 Familial persistent hyperinsulinemia (pancreatic KATP channel/
marize the content of the conference, and several moresulfonylurea receptor, SUR1) [19]
Congenital long QT syndrome—LQT2 (cardiac K channel, formal excerpts have been generously supplied by many
HERG) [20] of the participants to form this Symposium issue of Kid-Congenital long QT syndrome—LQT3 (cardiac Na channel,
ney International.SCN5A) [21]
Autosomal recessive retinitis pigmentosa (cGMP-gated channel,
CNCG1) [22]
Slow-channel myasthenic syndrome (muscle acetylcholine MECHANISMS OF ION CHANNEL
receptor, CHRNB1, CHRNE) [23, 24]
DYSFUNCTION: RELATINGNocturnal frontal lobe epilepsy (neuronal acetylcholine
receptor, CHRNA4) [25] STRUCTURE TO FUNCTION
1996 Bartter’s syndrome (renal K channel, ROMK) [26] The identification and functional characterization of
Congenital long QT syndrome—LQT1 (cardiac K channel,
ion channel mutations have, in many cases, revealedKvLQT1) [27]
Pseudohypoaldosteronism (epithelial Na channel, SCNN1A, important relationships between structure and function.
SCNN1B, SCNN1G) [28] This session highlighted several examples of this area of
Familial persistent hyperinsulinemia (pancreatic inward
investigation. The goal of this session was to correlaterectifier K channel, KCNJ11) [29]
Malignant hyperthermia susceptibility (muscle Ca channel, not only structure with function, but also phenotype with
CACLN1A3) [30] molecular and biophysical characteristics of ion channelFamilial hemiplegic migraine (Ca channel, CACNL1A4) [31]
dysfunction. Following a brief overview of ion channelEpisodic ataxia type 2 (Ca channel, CACNL1A4) [32]
structure and function given by Richard Horn (Jefferson1997 Bartter’s syndrome (renal Cl channel, CLCNKB) [33]
Congenital long QT syndrome—LQT5 (cardiac K channel Medical College), Stephen Cannon (Massachusetts Gen-
subunit, KCNE1) [34] eral Hospital, Harvard Medical School) reviewed theAutosomal dominant spinocerebellar ataxia type 6
spectrum of sodium channel gating disturbances in the(Ca channel, CACNL1A4) [35]
Jervell and Lange–Nielsen cardioauditory syndrome nondystrophic myotonias and periodic paralysis. These
(K channel, KvLQT1) [36]
primary muscle disorders illustrate some of the earliest
1998 Benign familial neonatal convulsions (K channel, KCNQ2) [37] defined and most extensively characterized ion channelBenign familial neonatal convulsions (K channel, KCNQ3) [38]
diseases. The subsequent presentations focused atten-Familial idiopathic ventricular fibrillation—Brugada syndrome
(cardiac Na channel, SCN5A) [39] tion on disorders caused by disturbances in ion channel
Generalized epilepsy with febrile seizures plus (Na channel b1
gating or permeation properties. Christopher Gomezsubunit, SCN1B) [40]
Total color blindness (cGMP-gated cation channel, CNGA3) (University of Minnesota) presented his work on mutant
[41] nicotinic acetylcholine receptors as causes of the slow
X-linked congenital stationary night blindness (Ca channel,
channel myasthenic syndromes. Bernard Rossier (Uni-CACNA1F ) [42, 43]
versity of Lausanne, Switzerland) discussed gain and loss1999 Sporadic long QT syndrome (K channel subunit, KCNE2) [44]
Autosomal dominant nonsyndromic deafness—DFNA2 of function in the epithelial sodium channel in Liddle’s
(K channel, KCNQ4) [45] syndrome and familial pseudohypoaldosteronism, re-
spectively. The final presentation of the session focused
on ion permeation defects in mutant chloride channels
(Christoph Fahlke, Vanderbilt University) and how this
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led to revealing important structural determinants of ion his work on the interactions between ion channels and
selectivity in the ClC family of chloride channels. the cytoskeleton, whereas Michael Kaplan (Yale Univer-
sity) presented his research on the importance of PDZ
domains in potassium channel targeting.
DEFECTIVE ION CHANNEL MOLECULAR
COMPLEXES AND ACCESSORY
SUBUNIT DYSFUNCTION ROLE OF ION CHANNEL DEFECTS IN
DISORDERS WITH COMPLEX ORThis session addressed the biology of accessory sub-
MULTISYSTEM PATHOPHYSIOLOGYunits and their role in the pathogenesis of ion channel
diseases. In the opening presentation, Lydia Aguilar- Some ion channel disorders present a complex and
Bryan (Baylor College of Medicine) described her work multisystem phenotype that is not readily explained by
on the sulfonylurea receptor (SUR) and inward rectifier, understanding the abnormal functional attributes of the
KIR6.2, the two main components of the pancreatic ATP- involved channel protein. Steve Hebert (Vanderbilt Uni-
sensitive potassium channel and the molecular genetic versity) provided an overview of this area, and then
basis for familial hyperinsulinemic hypoglycemia. Jacques Rajesh Thakker (Royal Post Graduate Medical School,
Barhanin (CRNS, France) discussed the role of another London, England) and Thomas Jentsch (University of
accessory subunit important for potassium channel func- Hamburg, Germany) discussed the pathogenesis of Dent’s
tion, minK, which has been linked to congenital long disease and the biology of the CLC-5 chloride channel.
QT syndrome and congenital deafness. Calcium channels The role of renal potassium and chloride channels in
are important regulators of muscle, cardiac, and neuro- complex disease pathogenesis was presented by David
neal excitability, and there are several types and isoforms Simon (Yale University), who related the common phe-
of accessory subunits. Miriam Misler (University of Michi- notypic expression of defects in multiple ion channels
gan) described her work identifying calcium channel ac- present in the thick ascending limb of the loop of Henle
cessory subunits as causes of central nervous system dis- to the clinical entity, Bartter’s syndrome. Finally, Kurt
orders. Beam (University of Colorado) discussed the spectrum
of the calcium channel diseases, including his important
work understanding disorders of excitation contractionDISORDERS INVOLVING ABNORMAL ION
coupling to illustrate how ion permeation is not the onlyCHANNEL ASSEMBLY TRAFFICKING
important function of ion channels.AND TARGETING
Structural mutations in ion channel proteins may not
always cause disease by directly interfering with function THERAPEUTIC STRATEGIES FOR
of the channel at the cell membrane. Several examples ION CHANNELOPATHIES
are known in which a molecular defect restricts or im-
In additional to understanding the pathophysiologicpedes the ability of the ion channel protein to assemble
basis for ion channel diseases, an important aspect ofor traffic in the cell. After an overview of protein traf-
this conference was a focus on the future developmentficking by Dennis Brown (Massachusetts General Hospi-
of novel therapeutic strategies specifically targeted total, Harvard Medical School, MA, USA), William Skach
mutant ion channels. This session highlighted examples(University of Pennsylvania, PA, USA) discussed defects
of new pharmacological and genetic approaches to suchin processing and trafficking of the cystic fibrosis gene,
therapy. Kim Lawson (Sheffield Hallam University, En-CFTR. Next, Carel Van Os (University of Nijmegen,
gland) presented an entertaining overview of an excitingThe Netherlands) described how defects in the post-
new class of drugs, potassium channel openers, as poten-translational processing of water channels cause the au-
tial therapeutic weapons in ion channel diseases causedtosomal form of nephrogenic diabetes insipidus. The
by potassium channel mutations. In the next presentation,third lecture given jointly by Daniella Rotin (University
Pamela Zeitlin (Johns Hopkins University) discussedof Toronto) and Olivier Staub (University of Lausanne)
pharmacologic strategies for restoring CFTR-mediatedexplained how defining the Liddle’s disease defect re-
chloride transport by employing chemical chaperones.vealed an important interplay between the epithelial so-
Richard Boucher (University of North Carolina) provideddium channel and Nedd4, a cytosolic protein–protein
an elegant overview of genetic approaches to treatmentinteraction critical for channel regulation. Because of
of genetic disease using cystic fibrosis as an illustration.the clear importance of understanding defects in protein
Finally, Eduardo Marban (Johns Hopkins University)trafficking, the last two lectures in this session expounded
presented a novel strategy for modifying cardiac andon more general biological themes relating to ion channel
neuroneal excitability by the introduction of ion channelsassembly and targeting. Dennis Ausiello (Massachusetts
General Hospital, Harvard Medical School) described into the heart and neurons with targeted viral vectors.
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skeletal muscle chloride channel in dominant and recessive humanFUTURE DIRECTIONS
myotonia. Science 257:797–800, 1992
9. George AL, Crackower MA, Abdalla JA, Hudson AJ, EbersAttendees and speakers who participated in “Ion Chan-
GC: Molecular basis of Thomsen’s disease (autosomal dominantnelopathies: Hereditary Dysfunction of Ion Channels”
myotonia congenita). Nat Genet 3:305–310, 1993
synergized to make an outstanding forum for discussing 10. Zhang Y, Chen HS, De Khanna VK, Leon S, Phillips MS, Schap-
pert K, Britt BA, Brownell AKW, MacLennan DH: A mutationthis fascinating topic. In the future, as the fruits of the
in the human ryanodine receptor gene associated with central coreHuman Genome Project are brought forth, we can expect
disease. Nat Genet 5:46–50, 1993
additional discoveries in the area of ion channel genetics. 11. Quane KA, Healy JMS, Keating KE, Manning BM, Couch FJ,
Palmucci LM, Doriguzzi C, Fagerlund TH, Berg K, Ording H,Participants of this landmark conference strongly sug-
Bendixen D, Mortier W, Linz U, Muller CR, McCarthy TV:gested planning for another such forum, possibly a Gor-
Mutations in the ryanodine receptor gene in central core disease
don Conference, to continue highlighting and dissemi- and malignant hyperthermia. Nat Genet 5:51–55, 1993
12. Shiang R, Ryan SG, Zhu Y-Z, Hahn AF, O’Connell P, Wasmuthnating important work in this area. We are all grateful
JJ: Mutations in the a1 of the inhibitory glycine receptor cause theto the International and American Societies of Nephrol-
dominant neurologic disorder, hyperekplexia. Nat Genet 5:351–
ogy for their foresight in promoting this scientific theme 358, 1993
13. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C,on the threshold of the new millennium.
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